Jump to content



Photo

VR Silver Newsletter 8/14/6


  • Please log in to reply
No replies to this topic

#1 TTHQ Staff

TTHQ Staff

    www.TTHQ.com

  • Admin
  • 8,597 posts

Posted 14 August 2006 - 09:14 AM

http://chart.bigcharts.com/custom/alliance/chart.asp?symb=GG&time=6mo&freq=1da&uf=7168&compidx=aaaaa:0&style=505&size=2&rand=3577

Posted Image


GERN - Geron Corporation 5.87

COMPANY PROFILE:


WHY WE LIKE IT: GERN has been in a solid downtrend for 2006. Our downside pricetargets have been hit and we are seeing some bullish divergences on our momentumindicators.

Geron Corporation operates as a biopharmaceutical company in the United States. Itdevelops and commercializes three groups of products: therapeutic products for oncologythat target telomerase; pharmaceuticals that activate telomerase in tissues impacted bysenescence, injury or degenerative disease; and cell-based therapies derived from itshuman embryonic stem cell platform for applications in various diseases. The companydevelops anti-cancer therapies based on telomerase inhibitors, telomerase therapeuticvaccines, as well as through its licensee, telomerase-based oncolytic viruses. It alsodevelops drugs that activate telomerase for cell repair/function in senescent tissuesimplicated in certain diseases. The company intends to use human embryonic stem celltechnology to enable the development of transplantation therapies by providing startingmaterial for the manufacture of cells and tissues; facilitate pharmaceutical research anddevelopment practices by providing cells for disease models and screening, as well as forassigning function to newly discovered genes; and accelerate research in humandevelopmental biology by identifying the genes that control human growth and development.Geron Corporation has a collaboration and license agreement with Corning, Inc. for thedevelopment and commercialization of synthetic surface matrices for the growth of humanembryonic stem cells. The company was incorporated in 1990 and is based in Menlo Park,California.

POTENTIAL TRIGGER: Buy at market with risk back to the August 2004 low of 5.15.Looking for 7.50.

Posted Image


KO - Coca Cola 44.52

COMPANY PROFILE:


WHY WE LIKE IT: The Coca-Cola Company engages in the manufacture, distribution,and marketing of nonalcoholic beverage concentrates and syrups worldwide. The company ofVRSilver Newsletter - 814200.ems fers nonalcoholic beverages, principally carbonated softdrinks, as well as noncarbonated beverages. Its beverage products comprise bottled andcanned soft drinks and beverages products. The company's products also include beverageconcentrates, such as flavoring ingredients and sweeteners; syrups, the beverageingredients produced by combining concentrates, sweeteners, and added water; and fountainsyrups that use equipment for mixing the syrups with carbonated or noncarbonated water forimmediate consumption, and are sold to fountain retailers, such as restaurants. TheCoca-Cola Company also produces and markets noncarbonated beverages, including waters andflavored waters, juice and juice drinks, sports drinks, and teas and coffees. The companysells its finished beverage products primarily to distributors. It sells its beverageconcentrates and syrups to bottling and canning operators, distributors, fountainwholesalers, and fountain retailers. The Coca-Cola Company was founded in 1886 and isheadquartered in Atlanta, Georgia

POTENTIAL TRIGGER: KO has been slowly recovering for months and has been on ourmonitor/buy list for nearly two years. A technical rally should carry the stock up to the48-50 range. A mental stop would be placed around 39.00.

Posted Image


SHORTS

Sorry, no Short Watchlist to Report

 

DISCLAIMER



This newsletter is a publication dedicated to the education of stock traders. Thenewsletter is an information service only. The information provided herein is not to beconstrued as an offer to buy or sell securities of any kind. The newsletter picks are notto be considered a recommendation of any stock but an information resource to aid theinvestor in making an informed decision regarding trading in stocks. It is possible atthis or some subsequent date, the editors and staff of VRTrader.com may own, buy or sellsecurities presented. All investors should consult a qualified professional before tradingin any security. The information provided has been obtained from sources deemed reliablebut is not guaranteed as to accuracy or completeness. VRTrader.com staff makes everyeffort to provide timely information to its subscribers but cannot guarantee specificdelivery times due to factors beyond our control.

Suggestions? Comments? on the newsletter service. We would like to hear from each andeveryone of our subscribers. Our email is mark@vrsurvey.com.